Haemonetics (HAE)River Road Asset Management, LLC reduced its stake -42K shares

1.29M

Shares reported · -42K vs prior quarter

1.1%

Disclosed portfolio weight

$96.4M

Reported value

Holdings as of

Jun 30, 2026

Filed

Jul 17, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Nov 4, 2025Federal contract · $6K obligatedDepartment of Defense awarded HAEMONETICS CORP: $6.1K obligated to date
2. Feb 12, 2026Federal contract · $88K obligatedDepartment of Defense awarded HAEMONETICS CORP: $88K obligated to date
3. Mar 10, 2026Federal contract · $50K obligatedDepartment of Veterans Affairs awarded HAEMONETICS CORP: $50K obligated to date
4. Apr 16, 2026Federal contract · $132K obligatedNational Aeronautics and Space Administration awarded HAEMONETICS CORP: $132K obligated to date
5. May 12, 2026Federal contract · $23K obligatedDepartment of Veterans Affairs awarded HAEMONETICS CORP: $23K obligated to date
6. May 19, 2026Federal contract · $84K obligatedDepartment of Defense awarded HAEMONETICS CORP: $84K obligated to date

What came next

1. Jul 24, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On July 24, 2026, the Board of Directors of Haemonetics Corporation (the “Company”) elected Martin Madaus as a director of the Company, effective immediately. Dr. Madaus currently serves as Senior Operating Executive at The Carlyle Group, where since 2019 he has advised on healthcare investments and portfolio company performance.”
2. Aug 6, 2026Company filing · Form 8-K · ResultsReported its results
3. Sep 14, 2026Federal contract · $27K obligatedDepartment of Veterans Affairs awarded HAEMONETICS CORP: $27K obligated to date

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Haemonetics

For Haemonetics, OQRO holds 7 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HAE page.

How this filing works

• SEC Form 13F

Other disclosures at Haemonetics

• USAspending.gov award recordSep 23, 2026
• USAspending.gov award recordSep 21, 2026
• USAspending.gov award recordSep 21, 2026
• USAspending.gov award recordSep 16, 2026
• USAspending.gov award recordSep 16, 2026
• USAspending.gov award recordAug 18, 2026

Everything OQRO holds on this company is on its HAE page.